Square Textiles PLC. announcements
256 Dhaka Stock Exchange announcements for Square Textiles PLC. (SQUARETEXT) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2008 (14).
- The company also informed that SEC has given consent to increase paid-up capital of Square Textiles Ltd. through issuanc
The company also informed that SEC has given consent to increase paid-up capital of Square Textiles Ltd. through issuance of 1,15,00,000 ordinary shares of Tk. 10.00 each in course of amalgamation of the company with Square Spinnings Ltd. The exchange rate for amalgamation to be 11.5 shares of Square Textiles Ltd. (Tk. 10 each) in exchange of 1 share of Square Spinnings Ltd. (Tk. 100 each) It may also be mentioned here that 98% shares of Square Spinnings Ltd. is being held by Square Pharmaceuticals Ltd. The company also reported in the annual report 2007 that EPS of Square Textiles Ltd. for the year 2007 would be Tk. 8.94 before merger and the EPS after merger would be Tk. 8.81 for the same period.
- SEC has given consent for raising paid up capital of Square Textile Ltd. from Tk. 39,43,33,700 to Tk. 50,93,33,700 only
SEC has given consent for raising paid up capital of Square Textile Ltd. from Tk. 39,43,33,700 to Tk. 50,93,33,700 only through issuance of 1,15,00,000 ordinary shares of Tk. 10.00 each at par in course of amalgamation of the company with Square Spinnings Ltd. The consent has been accorded subject to the condition that the company shall comply with relevant laws and regulatory requirements and with the order of the High Court Division of the Hon'ble Supreme Court of Bangladesh approving the above mentioned amalgamation scheme.
- As per un-audited half yearly accounts as on 30.06.08, the Company has reported consolidated profit after tax of Tk. 222
As per un-audited half yearly accounts as on 30.06.08, the Company has reported consolidated profit after tax of Tk. 222.47 m with consolidated EPS of Tk. 4.70 as against last year's half yearly of Tk. 158.15 m and Tk. 3.34 (restated) respectively.
- Square Spinnings Ltd., one of the corporate Sponsors of the Company, has further reported that it has completed its sale
Square Spinnings Ltd., one of the corporate Sponsors of the Company, has further reported that it has completed its sale of 2,32,874 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
- Square Spinnings Ltd., one of the corporate Sponsors of the Company, has reported its intention to sell its entire holdi
Square Spinnings Ltd., one of the corporate Sponsors of the Company, has reported its intention to sell its entire holdings of 2,32,874 shares of the Company at prevailing market price through Stock Exchange within next 30 working days.
- Square Pharmaceuticals Ltd., one of the Corporate Directors of the company has further reported that it has completed it
Square Pharmaceuticals Ltd., one of the Corporate Directors of the company has further reported that it has completed its sale of 5,00,000 shares of the company at prevailing market price through Stock Exchange as announced earlier.
- Normal trading of the shares of the company will resume on 18.05.08 after Record date and there will be no price limit o
Normal trading of the shares of the company will resume on 18.05.08 after Record date and there will be no price limit on the trading of the shares of the company for the same day.
- Trading of the shares of the company will remain suspended on record date i.e. 15.05.08.
Trading of the shares of the company will remain suspended on record date i.e. 15.05.08.
- Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 12.05.08 to 14.05.08. Trading of the shares of the company will remain suspended on record date i.e., 15.05.08.
- Square Pharmaceuticals Ltd., one of the Corporate Directors of the company has reported its intention to sell 5,00,000 s
Square Pharmaceuticals Ltd., one of the Corporate Directors of the company has reported its intention to sell 5,00,000 shares out of its total holdings of 1,38,75,545 shares of the company at prevailing market price through Stock Exchange within next 30 working days.
- The company has reported net profit after tax of Tk. 352.45 m with EPS of Tk. 8.94 as on 31.12.07 as against Tk. 348.83
The company has reported net profit after tax of Tk. 352.45 m with EPS of Tk. 8.94 as on 31.12.07 as against Tk. 348.83 m and Tk. 8.85 (restated) respectively as on 31.12.06.
- There will be no price limit on the trading of the shares of the company on 22.04.08 following its corporate declaration
There will be no price limit on the trading of the shares of the company on 22.04.08 following its corporate declaration.
- The Board of Directors has recommended cash dividend @ 25% and stock dividend @ 20% (20 Bonus shares for every 100 share
The Board of Directors has recommended cash dividend @ 25% and stock dividend @ 20% (20 Bonus shares for every 100 shares) for the year 2007. Date of AGM : 16.06.08, Time: 11.30 a.m., Venue: Bangladesh-China friendship Conference Centre, Agargaon, Dhaka. Record date: 15.05.08.
- As per regulation 30 of DSE Listing Regulations the company has informed that a meeting of the Board of Directors of the
As per regulation 30 of DSE Listing Regulations the company has informed that a meeting of the Board of Directors of the Company scheduled to be held on 21st April, 2008 at 9:30 a.m. in regard to consider its accounts for the year ended 31st December, 2008, appropriation of profits and about 13th Annual General Meeting of the shareholders.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.